Indeed, novel evidence supports the idea that in both anti-CTLA-4 and anti-PD-1 colitis, specific “favorable” or “unfavorable” microbiome profiles may affect the efficacy of the immune response and, consequently, the appearance of gastrointestinal irAEs (18, 19). Here, PDCD1 is linked to colitis.